Different clinical response to interferon beta and glatiramer acetate related to the presence of oligoclonal IgM bands in CSF in multiple sclerosis patients

被引：6

作者：

Casanova, Bonaventura ^{[1
]}

Lacruz, Laura ^{[1
]}

Villar, Maria Luisa ^{[2
]}

Dominguez, Jose Andres ^{[3
]}

Gadea, Maria Carcelen ^{[4
]}

Gascon, Francisco ^{[3
]}

Mallada, Javier ^{[5
]}

Hervas, David ^{[6
]}

Simo-Castello, Maria

Alvarez-Cermeno, Jose Carlos ^{[7
]}

Calles, Carmen ^{[8
]}

Olascoaga, Javier ^{[9
]}

Ramio-Torrenta, Lluis ^{[10
]}

Alcala, Carmen ^{[1
]}

Cervello, Angeles ^{[4
]}

Bosca, Isabel ^{[1
]}

Perez-Mirallles, Francisco Carlos ^{[1
]}

Coret, Francisco ^{[3
]}

机构：

[1] Hosp Univ & Politecn La Fe, Neuroimmunol Unit, Valencia, Spain

[2] Hosp Ramon y Cajal Madrid, Serv Immunol, Madrid, Spain

[3] Hosp Clin Univ Valencia, Neuroimmunol Unit, Valencia, Spain

[4] Hosp Gen Valencia, Neurol Serv, Valencia, Spain

[5] Hosp Elda, Neurol Serv, Alicante, Spain

[6] Inst Invest Sanitaria La Fe, Biostat Unit, Valencia, Spain

[7] Hosp Ramon y Cajal Madrid, Neurol Serv, Madrid, Spain

[8] Hosp Son Espases, Neurol Serv, Mallorca, Spain

[9] Hosp Donosti, Neurol Serv, San Sebastian, Spain

[10] Hosp Dr Josep Trueta, Neuroimmunol & Multiple Sclerosis Unit, IDIBGI, Girona, Spain

来源：

NEUROLOGICAL SCIENCES | 2018年 / 39卷 / 08期

关键词：

Relapsing-remitting multiple sclerosis; Beta interferon; Glatiramer acetate; Oligoclonal M bands; IMMUNOGLOBULIN-M; DOUBLE-BLIND; OPEN-LABEL; DISABILITY; MULTICENTER; PROGRESSION; PREDICT;

D O I：

10.1007/s10072-018-3442-y

中图分类号：

R74 [神经病学与精神病学];

学科分类号：

摘要：

To study the efficacy of interferon beta (IFN beta) and glatiramer acetate (GA) related to the presence of oligoclonal M bands (OCMB) in the cerebrospinal fluid in relapsing-remitting multiple sclerosis (RRMS). This is an observational, multicenter and retrospective study with prospectively collected data of patients that started treatment with IFN beta or GA. Treatment decision was made blinded to the OCMB status. Time to first attack after starting therapy was compared by using Kaplan-Meier curves, and adjustment by Cox regression analysis was performed. Two hundred and fifty-six patients entered in the study (141-55% received IFN beta; 115-45% received GA). After a mean follow-up of 41 and 65 months, 54.7% of patients remained free from further attacks (RF). The proportion of RF patients was higher in the GA group than in the IFN beta group (72.2 vs. 40.4%, p < 0.001). The IFN beta patients with OCMB+ presented the poorest response, 31.3% RF vs. 48.1% in IFN beta without OCMB, p = 0.03. OCMB in CSF could be a biomarker of treatment response in multiple sclerosis.

引用

页码：1423 / 1430

页数：8

共 29 条

[1] Absence of cerebrospinal fluid oligoclonal bands is associated with delayed disability progression in relapsing-remitting MS patients treated with interferon-β [J].

Annunziata, Pasquale ;

Giorgio, Antonio ;

De Santi, Lorenzo ;

Zipoli, Valentina ;

Portaccio, Emilio ;

Amato, Maria Pia ;

Clerici, Raffaella ;

Scarpini, Elio ;

Moscato, Gianluca ;

Iudice, Alfonso ;

Vacca, Giovanni ;

Orefice, Giuseppe ;

Morra, Vincenzo Brescia ;

Maimone, Davide .

JOURNAL OF THE NEUROLOGICAL SCIENCES, 2006, 244 (1-2) :97-102

[2] Response to interferon in multiple sclerosis is related to lipid-specific oligoclonal IgM bands [J].

Bosca, I. ;

Villar, L. M. ;

Coret, F. ;

Magraner, M. J. ;

Simo-Castello, M. ;

Alvarez-Cermeno, J. C. ;

Casanova, B. .

MULTIPLE SCLEROSIS JOURNAL, 2010, 16 (07) :810-815

[3] Glatiramer acetate and interferon beta-1b: a study of outcomes among patients with multiple sclerosis [J].

Castelli-Haley, Jane ;

Oleen-Burkey, MerriKay A. ;

Lage, Maureen J. ;

Johnson, Kenneth P. .

ADVANCES IN THERAPY, 2009, 26 (05) :552-562

[4] Cerebrospinal fluid oligoclonal bands in multiple sclerosis and clinically isolated syndromes: a meta-analysis of prevalence, prognosis and effect of latitude [J].

Dobson, Ruth ;

Ramagopalan, Sreeram ;

Davis, Angharad ;

Giovannoni, Gavin .

JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 2013, 84 (08) :909-914

[5] INTERFERON BETA-1B IS EFFECTIVE IN RELAPSING-REMITTING MULTIPLE-SCLEROSIS - CLINICAL-RESULTS OF A MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED TRIAL [J].

DUQUETTE, P ;

GIRARD, M ;

DESPAULT, L ;

DUBOIS, R ;

KNOBLER, RL ;

LUBLIN, FD ;

KELLEY, L ;

FRANCIS, GS ;

LAPIERRE, Y ;

ANTEL, J ;

FREEDMAN, M ;

HUM, S ;

GREENSTEIN, JI ;

MISHRA, B ;

MULDOON, J ;

WHITAKER, JN ;

EVANS, BK ;

LAYTON, B ;

SIBLEY, WA ;

LAGUNA, J ;

KRIKAWA, J ;

PATY, DW ;

OGER, JJ ;

KASTRUKOFF, LF ;

MOORE, GRW ;

HASHIMOTO, SA ;

MORRISON, W ;

NELSON, J ;

GOODIN, DS ;

MASSA, SM ;

GUTTERIDGE, E ;

ARNASON, BGW ;

NORONHA, A ;

REDER, AT ;

MARTIA, R ;

EBERS, GC ;

RICE, GPA ;

LESAUX, J ;

JOHNSON, KP ;

PANITCH, HS ;

BEVER, CT ;

CONWAY, K ;

WALLENBERG, JC ;

BEDELL, L ;

VANDENNOORT, S ;

WEINSHENKER, B ;

WEISS, W ;

REINGOLD, S ;

PACHNER, A ;

TAYLOR, W .

NEUROLOGY, 1993, 43 (04) :655-661

[6] Randomised double-blind placebo-controlled study of interferon β-1a in relapsing/remitting multiple sclerosis [J].

Ebers, GC ;

Rice, G ;

Lesaux, J ;

Paty, D ;

Oger, J ;

Li, DKB ;

Beall, S ;

Devonshire, V ;

Hashimoto, S ;

Hooge, J ;

Kastrukoff, L ;

Krieger, C ;

Mezei, M ;

Seland, P ;

Vorobeychi, G ;

Morrison, W ;

Nelson, J ;

Freedman, MS ;

Chrisie, S ;

Nelson, R ;

Rabinovitch, H ;

Freedman, C ;

Hartung, HP ;

Rieckmann, P ;

Archelos, J ;

Jung, S ;

Weilbach, F ;

Flachenecke, P ;

Sauer, J ;

Hommes, O ;

Jongen, P ;

Brouwer, S ;

McLeod, J ;

Pollard, J ;

Ng, R ;

Sandberg-Wollheim, M ;

Källén, K ;

Nilsson, P ;

Ekberg, R ;

Lundgren, A ;

Jadbäck, G ;

Wikström, J ;

Multanen, J ;

Valjakka, M ;

Carton, H ;

Lissoir, F ;

Declerq, I ;

Vieren, M ;

Peeters, E ;

Dubois, B .

LANCET, 1998, 352 (9139) :1498-1504

[7] Assessment of the reproducibility of oligoclonal IgM band detection for its application in daily clinical practice [J].

Espino, M. ;

Abraira, V. ;

Arroyo, R. ;

Bau, L. ;

Camara, C. ;

Campos-Ruiz, L. ;

Casanova, B. ;

Espejo, C. ;

Fernandez, O. ;

Garcia-Merino, A. ;

Garcia-Sanchez, M. I. ;

Gomez, M. ;

Gosis, A. ;

Izquierdo, G. ;

Meca, J. ;

Montalban, X. ;

Morandeira, F. ;

Olascoaga, J. ;

Prada, A. ;

Quintana, E. ;

Ramio-Torrenta, Ll. ;

Rodriguez-Antigueedad, A. ;

Salgado, G. ;

Santiago, J. L. ;

Sarasola, E. ;

Simo-Castello, M. ;

Alvarez-Cermeno, J. C. ;

Villar, L. M. .

CLINICA CHIMICA ACTA, 2015, 438 :67-69

[8] Cerebrospinal fluid oligoclonal IgM bands predict early conversion to clinically definite multiple sclerosis in patients with Clinically Isolated Syndrome [J].

Ferraro, Diana ;

Simone, Anna Maria ;

Bedin, Roberta ;

Galli, Veronica ;

Vitetta, Francesca ;

Federzoni, Lucia ;

D'Amico, Roberto ;

Merelli, Elisa ;

Nichelli, Paolo Frigio ;

Sola, Patrizia .

JOURNAL OF NEUROIMMUNOLOGY, 2013, 257 (1-2) :76-81

[9] Twenty-four-month comparison of immunomodulatory treatments -: a retrospective open label study in 308 RRMS patients treated with beta interferons or glatiramer acetate (Copaxone®) [J].

Haas, J ;

Firzlaff, M .

EUROPEAN JOURNAL OF NEUROLOGY, 2005, 12 (06) :425-431

[10] Intramuscular interferon beta-1 alpha for disease progression in relapsing multiple sclerosis [J].

Jacobs, LD ;

Cookfair, DL ;

Rudick, RA ;

Herndon, RM ;

Richert, JR ;

Salazar, AM ;

Fischer, JS ;

Goodkin, DE ;

Granger, CV ;

Simon, JH ;

Alam, JJ ;

Bartoszak, DM ;

Bourdette, DN ;

Braiman, J ;

Brownscheidle, CM ;

Coats, ME ;

Cohan, SL ;

Dougherty, DS ;

Kinkel, RP ;

Mass, MK ;

Munschauer, FE ;

Priore, RL ;

Pullicino, PM ;

Scherokman, BJ ;

WeinstockGuttman, B ;

Whitman, RH ;

Baird, WC ;

Fillmore, M ;

Bona, LM ;

ColonRuiz, ME ;

Nadine, BS ;

Donovan, A ;

Bennett, S ;

Kieffer, YM ;

Umhauer, MA ;

Miller, CE ;

Kilic, AK ;

Sargent, EL ;

Schachter, M ;

Shucard, DW ;

Weider, V ;

Catalano, BA ;

Cervi, JM ;

Czekay, C ;

Farrell, JL ;

Filippini, JS ;

Matyas, RC ;

Michienzi, KE ;

Ito, M ;

OMalley, JA .

ANNALS OF NEUROLOGY, 1996, 39 (03) :285-294

← 1 2 3 →